D.E. Shaw & Co’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.64M | Sell |
746,266
-1,235,997
| -62% | -$14.3M | 0.01% | 1137 |
|
|
2025
Q1 | $17.3M | Buy |
1,982,263
+763,665
| +63% | +$6.67M | 0.02% | 741 |
|
|
2024
Q4 | $17.5M | Buy |
+1,218,598
| New | +$17.5M | 0.01% | 728 |
|
|
2024
Q2 | – | Sell |
-64,799
| Closed | -$2.43M | – | 3480 |
|
|
2024
Q1 | $2.43M | Buy |
64,799
+59,855
| +1,211% | +$2.25M | ﹤0.01% | 1656 |
|
|
2023
Q4 | $277K | Sell |
4,944
-55,361
| -92% | -$3.1M | ﹤0.01% | 2586 |
|
|
2023
Q3 | $2.49M | Sell |
60,305
-47,225
| -44% | -$1.95M | ﹤0.01% | 1598 |
|
|
2023
Q2 | $6M | Buy |
107,530
+97,299
| +951% | +$5.43M | 0.01% | 1162 |
|
|
2023
Q1 | $571K | Sell |
10,231
-184,026
| -95% | -$10.3M | ﹤0.01% | 2460 |
|
|
2022
Q4 | $7.08M | Buy |
+194,257
| New | +$7.08M | 0.01% | 1229 |
|
|
2021
Q4 | – | Sell |
-3,402
| Closed | -$495K | – | 4228 |
|
|
2021
Q3 | $495K | Sell |
3,402
-32,334
| -90% | -$4.7M | ﹤0.01% | 2840 |
|
|
2021
Q2 | $7M | Sell |
35,736
-55,177
| -61% | -$10.8M | 0.01% | 1256 |
|
|
2021
Q1 | $16.5M | Sell |
90,913
-115,104
| -56% | -$20.8M | 0.02% | 781 |
|
|
2020
Q4 | $29.2M | Buy |
206,017
+63,898
| +45% | +$9.05M | 0.03% | 548 |
|
|
2020
Q3 | $17.7M | Buy |
+142,119
| New | +$17.7M | 0.02% | 658 |
|
|
2020
Q2 | – | Sell |
-10,973
| Closed | -$684K | – | 2841 |
|
|
2020
Q1 | $684K | Buy |
10,973
+6,970
| +174% | +$434K | ﹤0.01% | 2026 |
|
|
2019
Q4 | $305K | Buy |
+4,003
| New | +$305K | ﹤0.01% | 2356 |
|